Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.

Brinkhof MW, Spycher BD, Yiannoutsos C, Weigel R, Wood R, Messou E, Boulle A, Egger M, Sterne JA; International epidemiological Database to Evaluate AIDS (IeDEA).

PLoS One. 2010 Nov 30;5(11):e14149. doi: 10.1371/journal.pone.0014149.

2.

Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.

May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, Keiser O, Sterne JA, Dabis F, Egger M; IeDEA Southern Africa and West Africa.

Lancet. 2010 Aug 7;376(9739):449-57. doi: 10.1016/S0140-6736(10)60666-6. Epub 2010 Jul 15.

3.

Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.

Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, Fox MP, MacPhail P, van Cutsem G, Messou E, Wood R, Nash D, Pascoe M, Dickinson D, Etard JF, McIntyre JA, Brinkhof MW; IeDEA East Africa, West Africa and Southern Africa.

PLoS Med. 2011 Jan 18;8(1):e1000390. doi: 10.1371/journal.pmed.1000390.

4.

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.

Brinkhof MW, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, Dabis F, Pascoe M, Egger M; International Epidemiological Databases to Evaluate AIDS (IeDEA).

PLoS Med. 2009 Apr 28;6(4):e1000066. doi: 10.1371/journal.pmed.1000066. Epub 2009 Apr 28.

5.

Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.

Anaky MF, Duvignac J, Wemin L, Kouakoussui A, Karcher S, Touré S, Seyler C, Fassinou P, Dabis F, N'Dri-Yoman T, Anglaret X, Leroy V.

Bull World Health Organ. 2010 Jul 1;88(7):490-9. doi: 10.2471/BLT.09.068015. Epub 2009 Dec 21.

6.

Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.

Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, Maskew M, Prozesky H, Wood R, Johnson LF, Egger M, Boulle A, Myer L; International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration.

PLoS Med. 2012;9(9):e1001304. Epub 2012 Sep 4.

7.

Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.

Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, Keiser O; IeDEA Southern Africa.

Trop Med Int Health. 2012 Dec;17(12):1509-20. doi: 10.1111/j.1365-3156.2012.03089.x. Epub 2012 Sep 20. Review.

8.

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.

Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.

J Infect Dis. 2013 Jan 1;207(1):72-9. doi: 10.1093/infdis/jis635. Epub 2012 Oct 24.

9.
10.

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.

Keiser O, Chi BH, Gsponer T, Boulle A, Orrell C, Phiri S, Maxwell N, Maskew M, Prozesky H, Fox MP, Westfall A, Egger M; IeDEA Southern Africa Collaboration.

AIDS. 2011 Sep 10;25(14):1761-9. doi: 10.1097/QAD.0b013e328349822f.

11.

Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.

Van Cutsem G, Ford N, Hildebrand K, Goemaere E, Mathee S, Abrahams M, Coetzee D, Boulle A.

PLoS One. 2011 Feb 17;6(2):e14684. doi: 10.1371/journal.pone.0014684.

12.

AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.

Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H, Abo Y, Dakoury-Dogbo N, Toure S, Seyler C; ANRS 12222 Morbidity/Mortality Study Group.

Clin Infect Dis. 2012 Mar 1;54(5):714-23. doi: 10.1093/cid/cir898. Epub 2012 Feb 4.

13.

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.

Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, Keiser O, Lampe FC, Giddy J, Ndirangu J, Garone D, Fox M, Ingle SM, Reiss P, Dabis F, Costagliola D, Castagna A, Ehren K, Campbell C, Gill MJ, Saag M, Justice AC, Guest J, Crane HM, Egger M, Sterne JA.

PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014 Sep.

14.

Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.

Auld AF, Tuho MZ, Ekra KA, Shiraishi RW, Mohamed F, Kouakou JS, Ettiègne-Traoré V, Sabatier J, Essombo J, Rivadeneira ED, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV.

Pediatr Infect Dis J. 2014 Nov;33(11):1134-40. doi: 10.1097/INF.0000000000000457.

PMID:
25093975
15.

Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa.

Togun T, Peterson I, Jaffar S, Oko F, Okomo U, Peterson K, Jaye A.

AIDS Res Ther. 2011 Jul 20;8(1):24. doi: 10.1186/1742-6405-8-24.

16.

Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa.

Fox MP, Brennan A, Maskew M, MacPhail P, Sanne I.

Trop Med Int Health. 2010 Apr;15(4):405-13. doi: 10.1111/j.1365-3156.2010.02473.x. Epub 2010 Feb 17.

17.

How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa.

Slaymaker E, Todd J, Marston M, Calvert C, Michael D, Nakiyingi-Miiro J, Crampin A, Lutalo T, Herbst K, Zaba B.

Glob Health Action. 2014 Apr 22;7:22789. doi: 10.3402/gha.v7.22789. eCollection 2014.

18.

Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.

De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AM, Buonomo E, Prosperi MC, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):236-44. doi: 10.1097/QAI.0b013e31824276e9.

PMID:
22327246
19.

Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study.

Russell EC, Charalambous S, Pemba L, Churchyard GJ, Grant AD, Fielding K.

BMC Public Health. 2010 Jul 23;10:433. doi: 10.1186/1471-2458-10-433.

20.

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

Brinkhof MW, Pujades-Rodriguez M, Egger M.

PLoS One. 2009 Jun 4;4(6):e5790. doi: 10.1371/journal.pone.0005790.

Items per page

Supplemental Content

Write to the Help Desk